PE Ratio
23.55
₹1,295.70 -63.50 (-4.67%)
As on October 30, 2026
0.00%
1 Y CAGR
1,164
CR
Market Cap
Company profile
Established in 1972 and headquartered in Bhopal, India, 3B Blackbio Dx Limited specializes in the conception, production, and market distribution of sophisticated molecular diagnostic technologies. The company's core focus is on delivering solutions for pressing health concerns such as infectious diseases, oncology, human genetics, and the challenge of antimicrobial resistance, primarily serving the Indian market. Their comprehensive product portfolio includes qPCR-based assays, swift lateral flow rapid tests, and cutting-edge Next Generation Sequencing (NGS) molecular diagnostic kits. These offerings are designed to enable precise and dependable analysis of patient samples by diagnostic laboratories, marketed under reputable brands like TRUPCR, TRUNGS, and TRURAPID. Beyond diagnostics, 3B Blackbio Dx Limited also supplies agrochemical products and provides essential technical support and training services.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.51
Dividend Yield
0.30%
Sector PE
24.10
Sector ROE
17.88%
Sector Dividend Yield
1.09%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹1.4KCAGR 5-Year
+15.18%Peers & Comparison
JSWSTEEL
JSW Steel Ltd
Market cap: ₹3,05,952.21 Cr
ASIANPAINT
Asian Paints Ltd
Market cap: ₹2,42,278.18 Cr
HINDZINC
Hindustan Zinc Ltd
Market cap: ₹2,39,153.06 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
